Keyphrases
Risk Factors
100%
Clinical Impact
100%
Multidrug-resistant Pseudomonas Aeruginosa (MDRPA)
100%
Odds Ratio
42%
Survivors
28%
Pulsed-field Gel Electrophoresis
28%
Individual Risk Factors
28%
Epidemiologic
14%
Healthcare Facilities
14%
Comorbid Conditions
14%
High Risk
14%
Cephalosporins
14%
Aminoglycosides
14%
Demographic Characteristics
14%
Protective Factors
14%
Clinical Outcomes
14%
Multivariate Model
14%
Increased Mortality
14%
Hospital Stay
14%
Severe Outcomes
14%
Length of Hospital Stay
14%
Molecular Typing
14%
Multidrug-resistant
14%
Pseudomonas Aeruginosa (P. aeruginosa)
14%
Significant Risk Factors
14%
Epidemiology
14%
Rehabilitation Centers
14%
Non-invasive Device
14%
Hazard Ratio
14%
Intensive Care
14%
Intensive Care Unit
14%
Chronic Disease Management
14%
At Discharge
14%
Malignant Disease
14%
Critically Ill Patients
14%
Nosocomial Pathogens
14%
P. Aeruginosa Infection
14%
Matched Case-control Study
14%
Bedridden
14%
Calendar Time
14%
Antibiotic Agents
14%
Intensive Care Unit Stay
14%
Antibiotic Combination
14%
Adverse Clinical Outcomes
14%
Stay Time
14%
Matched Cohort Study
14%
Centre Care
14%
Nursing and Health Professions
Infection
100%
Odds Ratio
100%
Clinical Outcome
66%
Hospitalization
66%
Intensive Care Unit
66%
Pulsed Field Gel Electrophoresis
66%
Disease
33%
Cohort Analysis
33%
Rehabilitation Center
33%
Case-Control Study
33%
Antibiotic Agent
33%
Ward
33%
Intensive Care
33%
Immobility
33%
Hazard Ratio
33%
Molecular Typing
33%
Cephalosporin Derivative
33%
Aminoglycoside
33%
Medicine and Dentistry
Pseudomonas aeruginosa
100%
Odds Ratio
37%
Infection
37%
Intensive Care Unit
25%
Pulsed Field Gel Electrophoresis
25%
Disease
12%
Cohort Effect
12%
Cohort Analysis
12%
Case-Control Study
12%
Pathogen
12%
Antibiotics
12%
Protective Factor
12%
Rehabilitation Center
12%
Demography
12%
Hazard Ratio
12%
Intensive Care
12%
Aminoglycoside
12%
Immobility
12%
Invasive Device
12%
Cephalosporin Derivative
12%
Molecular Typing
12%
Pharmacology, Toxicology and Pharmaceutical Science
Pseudomonas aeruginosa
100%
Infection
37%
Pulsed-Field Gel Electrophoresis
25%
Cohort Study
12%
Disease
12%
Antibiotic Agent
12%
Aminoglycoside
12%
Case-Control Study
12%
Infectious Agent
12%
Cephalosporin Derivative
12%
Immobility
12%